Quantcast

Latest Pre-exposure prophylaxis Stories

2011-07-13 13:38:40

In a result that will fundamentally change approaches to HIV prevention in Africa, an international study has demonstrated that individuals at high risk for HIV infection who took a daily tablet containing an HIV medication "“ either the antiretroviral medication tenofovir or tenofovir in combination with emtricitabine "“ experienced significantly fewer HIV infections than those who received a placebo pill. These findings are clear evidence that this new HIV prevention strategy,...

2011-07-13 13:37:13

Microbicide Trials Network statement on the Partners PrEP study and the CDC's TDF2 study Today, researchers from two major HIV prevention trials announced favorable results of an approach called oral pre-exposure prophylaxis, or PrEP. One of these trials, the Partners PrEP Study, has provided the strongest evidence yet of PrEP's effectiveness. Information from both studies will need to be fully evaluated before it can be determined what impact they will have on another major trial that is...

2011-07-13 05:21:00

NEW YORK, July 13, 2011 /PRNewswire-USNewswire/ -- Results from two African studies of pre-exposure prophylaxis, or PrEP, released today provide clear evidence that the antiretroviral drugs used to treat HIV can also be used to prevent HIV among heterosexual men and women at risk of HIV infection. "These results are tremendously exciting and confirm that we are at pivotal period in the AIDS epidemic," said Mitchell Warren, AVAC executive director. "Antiretroviral (ARV) drugs for HIV...

2011-06-03 13:10:35

In a recent clinical trial, non"“HIV-infected individuals who used the antiretroviral drug Truvada on a daily basis cut their risk of becoming infected with HIV by 44 percent. While the findings are reason for great optimism, researchers say it is now important to understand the factors that could influence the public's willingness to use the drug in this way, known as pre-exposure prophylaxis, or PrEP. Scientists, health authorities and policymakers are currently debating the pros and...

2011-05-18 16:21:29

A new study from the University of North Carolina at Chapel Hill School of Medicine further validates the use of humanized BLT mice in the fight to block HIV transmission. The more than 2.7 million new HIV infections recorded per year leave little doubt that the HIV/AIDS epidemic continues to spread globally. That's why there's the need for safe, inexpensive and effective drugs to successfully block HIV transmission. A new study from the University of North Carolina at Chapel Hill School of...

2011-05-18 08:14:00

Argues AIDS vaccine research is a key part of the HIV prevention revolution NEW YORK, May 18, 2011 /PRNewswire-USNewswire/ -- This year HIV Vaccine Awareness Day comes at the dawn of a true prevention revolution that could finally turn the tide of the AIDS epidemic. AIDS vaccine research is a critical part of that revolution and on this day AVAC calls on donors, policy makers and others to strengthen support for AIDS vaccine research. "This is an exciting time in HIV prevention...

2011-03-14 15:05:27

The first human studies of an oral drug regimen to prevent HIV infection in high-risk individuals yielded a promising near 50% reduction in HIV incidence, but a number of issues require additional research before oral pre-exposure prophylaxis (PrEP) can be implemented on a large scale, according to an article in AIDS Patient Care and STDs, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article is available free online at www.liebertpub.com/apc After the...

2011-02-28 14:14:46

Preferences for HIV prevention products differ among US and African women In the first study to make head-to-head comparisons between tenofovir gel and oral tenofovir "“ two promising approaches for preventing HIV in women "“ researchers found that daily use of the vaginal gel achieved a more than 100-times higher concentration of active drug in vaginal tissue than did the oral tablet, while, compared to the gel, the tablet used daily was associated with a 20-times higher active...

2011-02-28 14:11:40

Strongest effect seen in tissue taken from participants after 1 week of use A gel developed to protect against HIV during vaginal sex produced a strong antiviral effect when used in the rectum, according to an early-phase study presented today at the 18th Conference on Retroviruses and Opportunistic Infections (CROI). The results, based on rectal tissue biopsies sampled from HIV-negative men and women who used the product daily for one week, provide the first-ever evidence that tenofovir gel...

2010-12-23 12:56:00

WASHINGTON, Dec. 23, 2010 /PRNewswire-USNewswire/ -- On December 17, Science Magazine recognized a promising HIV study as one of the top ten achievements of 2010. The groundbreaking research provided the first-ever proof of concept that a microbicide can effectively and safely reduce HIV transmission in women. Ninety percent of the study was funded by USAID as part of the U.S. President's Emergency Plan for AIDS Relief. (Logo: http://photos.prnewswire.com/prnh/20091022/USAIDLOGO) The...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin